Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332813 · ClinicalTrials.gov registry record · Phase 1
Reducing HIV Risk Among Pregnant Women in Drug Treatment
A Phase 1 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 98
- Enrollment target
NCT00332813 is a Phase 1 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 98 participants.
The verdict
NCT00332813, a Phase 1 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 98 participants
- Enrollment target
Study Summary
We propose to develop and pilot test an intervention that addresses both sex- and drug-related HIV risk behavior among pregnant women in drug treatment. In the first phase of the study, we will conduct focus groups with pregnant women in drug treatment, as well as a focus group with their treatment providers, in order to determine key areas of emphasis for an intervention in this population. We will then develop an HIV risk behavior intervention for pregnant women in drug treatment, pilot the intervention with 20 women, and elicit their feedback regarding the intervention. Following refinement of the intervention, we will conduct a small randomized trial (n=60) to examine the impact of the intervention compared to standard care (SC). We expect that, relative to SC, participants randomized to the intervention condition will have lower levels of sex- and drug-related HIV risk behavior.
Interventions
- BEHAVIORAL HIV Risk Behavior Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2006-02 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00332813
The ClinicalTrials.gov registry entry for NCT00332813 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HIV Risk Behavior Intervention is the first listed.
NCT00332813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00332813 about?
NCT00332813 is a clinical study titled "Reducing HIV Risk Among Pregnant Women in Drug Treatment". We propose to develop and pilot test an intervention that addresses both sex- and drug-related HIV risk behavior among pregnant women in drug treatment. In the first phase of the study, we will conduct focus groups with pregnant women in drug treatment, as well as a focus group with their treatment ...
What is the current status of trial NCT00332813?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 98 participants. The study started on 2006-02. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00332813?
The interventions under investigation include: HIV Risk Behavior Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00332813?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.